PAULET, ALEXANDRA
PAULET, ALEXANDRA
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift
2025 Massaro G, Paulet A, Lavacchi D, Brugia M, Rossini D, Giommoni E, Catalano M, Pillozzi S, Antonuzzo L, Roviello G.
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
2025 Catalano, Martina; Cekrezi, Gestiana; De Gennaro Aquino, Irene; Ravizza, Delia; Paulet, Alexandra; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma
2025 Catalano, Martina; de Gennaro Aquino, Irene; Vascotto, Ismaela Anna; Guarino, Adriana; Mancini, Silvia; Doni, Laura; Paulet, Alexandra; Rossi, Virginia; Giorgione, Roberta; Nesi, Gabriella; Antonuzzo, Lorenzo; Roviello, Giandomenico
Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratification
2026 Catalano, Martina; Bartoli, Sara; Salfi, Alessia; Bonalda, Mirko; Della Seta, Lorenzo; Paulet, Alexandra; Bloise, Francesco; Paolieri, Federico; Galli, Luca; Sisani, Michele; Doni, Laura; Perrella, Armando; Antonuzzo, Lorenzo; Roviello, Giandomenico
The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitors
2026 Paulet, Alexandra; Mancini, Silvia; Catalano, Martina; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift | 2025 | Massaro G, Paulet A, Lavacchi D, Brugia M, Rossini D, Giommoni E, Catalano M, Pillozzi S, Antonuzzo L, Roviello G. | |
| Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer | 2025 | Catalano, Martina; Cekrezi, Gestiana; De Gennaro Aquino, Irene; Ravizza, Delia; Paulet, Alexandra; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico | |
| Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma | 2025 | Catalano, Martina; de Gennaro Aquino, Irene; Vascotto, Ismaela Anna; Guarino, Adriana; Mancini, Silvia; Doni, Laura; Paulet, Alexandra; Rossi, Virginia; Giorgione, Roberta; Nesi, Gabriella; Antonuzzo, Lorenzo; Roviello, Giandomenico | |
| Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratification | 2026 | Catalano, Martina; Bartoli, Sara; Salfi, Alessia; Bonalda, Mirko; Della Seta, Lorenzo; Paulet, Alexandra; Bloise, Francesco; Paolieri, Federico; Galli, Luca; Sisani, Michele; Doni, Laura; Perrella, Armando; Antonuzzo, Lorenzo; Roviello, Giandomenico | |
| The good, the bad, and the manageable: real-world outcomes with CDK4/6 inhibitors | 2026 | Paulet, Alexandra; Mancini, Silvia; Catalano, Martina; Shtembari, Kristian; De Angelis, Claudia; Petrioli, Roberto; Generali, Daniele; Roviello, Giandomenico |